RBC Capital raises Aptiv stock price target to $82

Fintel reports that on February 10, 2025, RBC Capital downgraded their outlook for Pliant Therapeutics (NasdaqGS:PLRX) from ...
RBC Capital analyst Brian Abrahams maintained a Buy rating on Karyopharm Therapeutics (KPTI – Research Report) today and set a price target of ...
In this article, we are going to take a look at where International Business Machines Corporation (NYSE:IBM) stands against ...
Northern Trust Corporation announced today that Chief Financial Officer David Fox and Wealth Management President Jason Tyler will participate in the RBC 2025 Capital Markets Global Financial ...
"Prices have moved up nearly 16% since Thursday with no 'normal' reasons that could justify this price action," Tyler Broda, an RBC Capital Markets analyst, said in a February 1 research note.
What should I know about this firm? RBC Capital Markets LLC matches individual investors, retirees, families, executives and business owners with a financial advisor based on their money-related ...
APi Group (NYSE:APG) on Tuesday was upgraded to Outperform from a previous investment rating of Sector Perform by analysts at financial-services firm RBC Capital Markets. They said the provider of ...
Autonomous cars are evolving fast. RBC Capital Markets believes that within five to ten years, advances in artificial intelligence and robotics will see automated cars introduced with so-called ...
Brad Erickson of RBC Capital Markets discusses the investor outlook for AI as companies continue to bet big on the tech and ...